Join us for the Regenerative Engineering & Medicine Center's annual retreat, hosted by the University of Georgia, Georgia Tech, and Emory University. Advances in the delivery of molecular and biological therapeutics that will enhance the body’s ability to heal itself will be discussed, along with opportunities to meet and collaborate with PIs who will apply to the 2021-2022 "Therapeutic Delivery Innovation Initiative" collaborative grant RFA on this topic. CLICK HERE for complete seed grant into - Submision Deadline June 25, 2021.
REGISTER HERE for Participation Link
MAY 10, 2021
10:30 a.m. Introductory remarks – Steven Stice, Ph.D., University of Georgia
10:35 a.m. Keynote Presentation - "Universal Vaccines for Flu and COVID-19" - Ted Ross, Ph.D. - Director, GRA Eminent Scholar of Infectious Diseases, Professor, Animal Health Research Center, Center for Vaccines and Immunology, Department of Infectious Diseases - University of Georgia
11:05 a.m. Julie Champion, Ph.D. - Georgia Tech
11:20 a.m. Yao Yao, Ph.D. - University of Georgia
11:35 a.m. break
11:45 a.m. Hicham Drissi, Ph.D. - Emory University
12:00 p.m. Breakout "Rooms" on Zoom (links to be provided):
Session A - Making New Drugs (Including Biologics)
- Panelists representing:
- Host: Edmund Waller, M.D.-Ph.D. - Emory University
Session B - Targeted Drug Delivery
- Host: Steven Stice, Ph.D. - University of Georgia
Session C - Longer Acting or Enhanced Drugs
- Host: Susan Thomas, Ph.D. - Georgia Tech
12:30 p.m. Adjourn
Accelerate therapeutic delivery innovation and translation to treat disease. REM’s initiative will achieve this goal, which will position Georgia as a leading innovation hub in this intellectual space and benefit Georgia’s knowledge economy, by fostering interdisciplinary and multi-institutional collaborations and supporting research ranging from fundamental to translational to positively impact human health.
The goal of this initiative is to support drug delivery research that has high innovation and potential for translational impact among diverse investigators at Emory, Georgia Tech and University of Georgia in the areas of tissue regeneration, cell therapy, and immune modulation.